These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1010 related items for PubMed ID: 11061539

  • 21. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V, Di Biase S, Lettiero T, Labella D, Simeone R, Salerno M.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [Abstract] [Full Text] [Related]

  • 22. Metabolic Health in Short Children Born Small for Gestational Age Treated With Growth Hormone and Gonadotropin-Releasing Hormone Analog: Results of a Randomized, Dose-Response Trial.
    van der Steen M, Lem AJ, van der Kaay DC, Bakker-van Waarde WM, van der Hulst FJ, Neijens FS, Noordam C, Odink RJ, Oostdijk W, Schroor EJ, Westerlaken C, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3725-34. PubMed ID: 26259134
    [Abstract] [Full Text] [Related]

  • 23. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children.
    Boguszewski M, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2599-606. PubMed ID: 7673401
    [Abstract] [Full Text] [Related]

  • 24. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency.
    Martin DD, Schweizer R, Schönau E, Binder G, Ranke MB.
    Horm Res; 2009 Sep; 72(1):38-45. PubMed ID: 19571558
    [Abstract] [Full Text] [Related]

  • 25. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ, van der Kaay DC, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [Abstract] [Full Text] [Related]

  • 26. Body proportions during 6 years of GH treatment in children with short stature born small for gestational age participating in a randomised, double-blind, dose-response trial.
    Sas TC, Gerver WJ, De Bruin R, Mulder PG, Cole TJ, De Waal W, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2000 Dec; 53(6):675-81. PubMed ID: 11155088
    [Abstract] [Full Text] [Related]

  • 27. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
    de Kort SW, Willemsen RH, van der Kaay DC, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):65-73. PubMed ID: 19094073
    [Abstract] [Full Text] [Related]

  • 28. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome.
    Van Pareren YK, De Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Drop SL.
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5442-8. PubMed ID: 12466334
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Price DA.
    Horm Res; 2005 Dec; 63(1):40-7. PubMed ID: 15627781
    [Abstract] [Full Text] [Related]

  • 31. High-dose growth hormone treatment of short children born small for gestational age.
    de Zegher F, Maes M, Gargosky SE, Heinrichs C, Du Caju MV, Thiry G, De Schepper J, Craen M, Breysem L, Löfström A, Jönsson P, Bourguignon JP, Malvaux P, Rosenfeld RG.
    J Clin Endocrinol Metab; 1996 May; 81(5):1887-92. PubMed ID: 8626853
    [Abstract] [Full Text] [Related]

  • 32. Effects of growth hormone treatment on cognitive function and head circumference in children born small for gestational age.
    Hokken-Koelega A, van Pareren Y, Arends N.
    Horm Res; 2005 May; 64 Suppl 3():95-9. PubMed ID: 16439851
    [Abstract] [Full Text] [Related]

  • 33. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ, Boonstra VH, Mulder PG, Odink RJ, Stokvis-Brantsma WH, Rongen-Westerlaken C, Mulder JC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [Abstract] [Full Text] [Related]

  • 34. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
    de Muinck Keizer-Schrama SM, Rikken B, Wynne HJ, Hokken-Koelega AC, Wit JM, Bot A, Drop SL.
    J Clin Endocrinol Metab; 1992 Apr; 74(4):898-905. PubMed ID: 1548357
    [Abstract] [Full Text] [Related]

  • 35. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC, Stijnen T, De Jong MC, Donckerwolcke RA, De Muinck Keizer-Schrama SM, Blum WF, Drop SL.
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [Abstract] [Full Text] [Related]

  • 36. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.
    Underwood LE, Attie KM, Baptista J, Genentech Collaborative Study Group.
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5273-80. PubMed ID: 14602761
    [Abstract] [Full Text] [Related]

  • 37. Independent effects of prematurity on metabolic and cardiovascular risk factors in short small-for-gestational-age children.
    Willemsen RH, de Kort SW, van der Kaay DC, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2008 Feb; 93(2):452-8. PubMed ID: 18029462
    [Abstract] [Full Text] [Related]

  • 38. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH, Arends NJ, Bakker-van Waarde WM, Jansen M, van Mil EG, Mulder J, Odink RJ, Reeser M, Rongen-Westerlaken C, Stokvis-Brantsma WH, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [Abstract] [Full Text] [Related]

  • 39. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM, van Doorn J, Mulder PG, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [Abstract] [Full Text] [Related]

  • 40. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term.
    de Zegher F, Hokken-Koelega A.
    Pediatrics; 2005 Apr; 115(4):e458-62. PubMed ID: 15805349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.